Abound Wealth Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6
Closed -$139 1590
2025
Q4
$139 Hold
6
﹤0.01% 1316
2025
Q3
$162 Hold
6
﹤0.01% 1193
2025
Q2
$101 Hold
6
﹤0.01% 1256
2025
Q1
$106 Hold
6
﹤0.01% 1225
2024
Q4
$146 Hold
6
﹤0.01% 1175
2024
Q3
$223 Hold
6
﹤0.01% 1100
2024
Q2
$286 Sell
6
-1
-14% -$44 ﹤0.01% 997
2024
Q1
$268 Hold
7
﹤0.01% 1172
2023
Q4
$219 Buy
+7
New +$251 ﹤0.01% 1263

Other funds holding STAA

Abound Wealth Management's STAA Position: Q1 2026 in Review

Abound Wealth Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 6 shares — an estimated $139 sold.

Abound Wealth Management first reported a position in STAA in Q4 2023 and held it in 9 quarters. The position peaked at $286 in Q2 2024. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Abound Wealth Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • Abound Wealth Management sold 6 STAAR Surgical shares in Q1 2026, an estimated $139.
  • Abound Wealth Management first reported a position in STAAR Surgical in Q4 2023 and held it in 9 quarters.
  • Abound Wealth Management's STAAR Surgical position peaked at $286 in Q2 2024.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Abound Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.